← Back to Search

Multi-sensory Rehabilitation for Low Vision

N/A
Recruiting
Led By Arathy Kartha, PhD
Research Sponsored by State University of New York College of Optometry
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must not have
Dependent on sighted guide
Age <12 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month, 3 months, 6 months
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to improve vision rehabilitation for people with severe visual impairment by testing a new approach that involves multiple senses. Many clinical trials are recruiting participants with advanced eye diseases, but the best rehabilitation plan after

Who is the study for?
This trial is for individuals with ultra low vision, meaning their visual acuity is at or below 20/1600. It's designed to help improve their quality of life by testing a new rehabilitation program.
What is being tested?
The study tests a multi-sensory rehabilitation program that includes Visual Information Training and Multimodal training, aiming to fill the gap in current treatments for those with profound visual impairment.
What are the potential side effects?
Since this trial involves non-invasive training programs rather than medication, traditional side effects are not expected; however, participants may experience fatigue or frustration during the learning process.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I rely on someone to help me see or get around.
Select...
I am under 12 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 3 months, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in visual ability
Secondary study objectives
Change in hand-eye coordination
Change in hearing ability

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Visual Information TrainingExperimental Treatment1 Intervention
Group II: Multimodal TrainingExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Multimodal training
2019
N/A
~40

Find a Location

Who is running the clinical trial?

State University of New York College of OptometryLead Sponsor
19 Previous Clinical Trials
1,100 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,323 Previous Clinical Trials
14,874,264 Total Patients Enrolled
Arathy Kartha, PhDPrincipal InvestigatorState University of New York College of Optometry
~10 spots leftby Mar 2025